Cream and gel are often discussed as if they were two textures of the same medicine. That is too simple for testosterone treatment. The exact product can differ in concentration, ingredients, approval status, application instructions, and precautions around other people.
For someone who regularly holds grandchildren, shares close contact with a partner, or has difficulty following a daily skin routine, those details can influence whether topical treatment is workable. This guide prepares questions for a prescriber and pharmacist; it does not supply instructions for a particular compounded cream.
KEEP IN MIND
The useful bits.
- A compounded cream does not inherit a gel’s FDA approval.
- Application and contact precautions must match the exact product.
- Topical testosterone still requires clinical monitoring.
Begin with the full product name
AndroGel 1.62% is an example of an FDA-approved testosterone gel with product-specific prescribing information. A compounded testosterone cream does not share that approval. FDA does not review compounded preparations for safety, effectiveness, and quality before they are marketed in the way it reviews approved medicines.
Ask whether the proposed prescription is an approved manufactured product or a compounded preparation. Then ask why that choice fits your needs and which pharmacy will dispense it. The compounding guide explains why the active ingredient alone cannot answer the approval question.
Sources: DailyMed: AndroGel 1.62% prescribing information · FDA: understanding the risks of compounded drugs
Do not borrow an application routine
The application site, amount, drying requirements, and timing around bathing can depend on the specific medicine. Directions from a gel label should not be automatically applied to a cream, another concentration, or another product. A friend’s successful routine is not a substitute for your own prescription instructions.
Have the pharmacist explain the container, measuring device, and label in language you can easily repeat. If print is small or the dispensing mechanism is awkward, ask for help before the first use. Tell the prescriber if hand strength, vision, memory, or a variable daily schedule could make the prescribed routine difficult.
Sources: DailyMed: AndroGel 1.62% prescribing information · FDA: understanding the risks of compounded drugs
Discuss contact with other people
AndroGel’s label includes precautions about secondary exposure, especially in children. Its instructions address measures such as hand washing, covering the application area after drying, and washing the area before anticipated direct skin contact. These are product-specific directions, not a universal schedule for all topical testosterone.
Describe normal household contact to the clinician. Holding a child, helping someone dress, and close contact with a partner may require planning. Ask what precautions apply to your actual medicine and whom to contact after accidental exposure. Keep the product out of reach and do not let another person use it.
Skin delivery still requires medical follow-up
A medicine applied to skin can have effects throughout the body. Monitoring does not stop being necessary because there is no injection. Ask how symptoms, testosterone levels, blood counts, blood pressure, and other relevant concerns will be followed, and how the care team decides whether the treatment is helping.
Discuss fertility before treatment as well. Topical testosterone is not automatically fertility preserving. If your clinician proposes a change in route, ask how to make the transition and when to obtain follow-up testing. Do not apply more product or combine preparations because symptoms persist between appointments.
Sources: Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes · AUA/ASRM: male infertility guideline, amended 2024
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 23, 2026; prices and availability can change.
- DailyMed: AndroGel 1.62% prescribing information
- FDA: understanding the risks of compounded drugs
- Endocrine Society: testosterone therapy clinical guidance
- FDA: 2025 testosterone labeling and blood pressure changes
- AUA/ASRM: male infertility guideline, amended 2024
- Fountain: TRT options and four-week, 12-week, and 48-week billing
- Maximus: testosterone treatment options
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.